P2嘌呤能受体激动剂,ATPγS tetralithium salt is an analogue of ATP, acting as a potent agonist of G protein-coupled P2Y2 and P2Y11 receptors (pEC50 = 5.52 for P2Y11) [1].
P2嘌呤能受体激动剂,ATPγS tetralithium salt is an analogue of ATP, acting as a potent agonist of G protein-coupled P2Y2 and P2Y11 receptors (pEC50 = 5.52 for P2Y11) [1].
生物活性
ATPγS (tetralithium salt) is a substrate for the nucleotide hydrolysis and RNA unwinding activities of eukaryotic translation initiation factor eIF4A.
性状
Solid
体外研究(In Vitro)
ATPγS (tetralithium salt) enhances intrinsic fluorescence and induces aggregation which increases the activity of spinach Rubisco activase.
ATPγS (50-100 μM final blood concentration) attenuates inflammatory response with decreased accumulation of cells (48%, P < 0.01) and proteins (57%, P < 0.01) in bronchoalveolar lavage and reduces neutrophil infiltration and extravasation of Evans blue albumin dye into lung tissue.
Medlife has not independently confirmed the accuracy of these methods. They are for reference only.
体内研究(In Vivo)
ATPγS (tetralithium salt, 50 μM final, intravenous) demonstrates preserved lung parenchymal architecture.
ATPγS results in a dose-dependent effect on EBA extravasation in LPS-treated mice.
Medlife has not independently confirmed the accuracy of these methods. They are for reference only.